Celsius' (CELH) "Buy" Rating Reaffirmed at B. Riley Financial

Key Points

• B. Riley reaffirmed its Buy rating on Celsius but cut its price target from $56 to $53, implying 67.76% upside from the prior close.
• Analyst opinions are mixed, though the overall consensus is Moderate Buy, with an average price target of $42.39.
• Celsius beat quarterly earnings and revenue estimates, reporting $0.41 per share and $847.23 million in revenue; sales increased 16.8% year over year.

Celsius (NASDAQ:CELH - Get Free Report)'s stock had its "buy" rating reissued by analysts at B. Riley Financial in a research report issued on Friday, Benzinga reports. They currently have a $53.00 target price on the stock, down from their prior target price of $56.00. B. Riley Financial's price objective would suggest a potential upside of 67.76% from the company's previous close.

Several other research firms have also issued reports on CELH. Needham & Company LLC upped their target price on Celsius from $35.00 to $40.00 and gave the company a "buy" rating in a report on Friday. Sanford C. Bernstein lowered Celsius from an "outperform" rating to a "market perform" rating and dropped their price target for the stock from $44.00 to $26.00 in a report on Friday, August 7th. The Goldman Sachs Group set a $45.00 price objective on Celsius in a research report on Monday, August 10th. Weiss Ratings downgraded Celsius from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Tuesday, August 11th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $36.00 target price on shares of Celsius in a research report on Monday, August 24th. Fourteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Celsius presently has an average rating of "Moderate Buy" and a consensus price target of $42.39.

Celsius Stock Up 5.2%

Celsius stock traded up $1.55 during midday trading on Friday, hitting $31.59. 1,842,486 shares of the stock were exchanged, compared to its average volume of 7,710,635. Celsius has a 52-week low of $23.56 and a 52-week high of $59.31. The stock has a market capitalization of $7.99 billion, a price-to-earnings ratio of 130.68, a price-to-earnings-growth ratio of 2.22 and a beta of 1.00. The business's 50-day moving average price is $28.76 and its 200-day moving average price is $34.25. The company has a quick ratio of 1.42, a current ratio of 1.80 and a debt-to-equity ratio of 0.56.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.34 by $0.07. Celsius had a net margin of 4.24% and a return on equity of 36.52%. The business had revenue of $847.23 million during the quarter, compared to the consensus estimate of $800.63 million. During the same period in the prior year, the firm posted ($0.27) EPS. The firm's quarterly revenue was up 16.8% compared to the same quarter last year. On average, research analysts expect that Celsius will post 1.42 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Damon DeSantis acquired 16,000 shares of the company's stock in a transaction that occurred on Tuesday, September 15th. The shares were acquired at an average price of $27.95 per share, for a total transaction of $447,200.00. Following the completion of the purchase, the director owned 2,728,187 shares in the company, valued at approximately $76,252,826.65. This trade represents a 0.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO John Fieldly acquired 18,000 shares of the company's stock in a transaction that occurred on Thursday, September 10th. The stock was purchased at an average price of $27.44 per share, for a total transaction of $493,920.00. Following the purchase, the chief executive officer owned 956,063 shares of the company's stock, valued at $26,234,368.72. The trade was a 1.92% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have purchased 66,000 shares of company stock valued at $1,830,120. 2.33% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. State Street Corp lifted its stake in shares of Celsius by 4.5% during the 2nd quarter. State Street Corp now owns 5,253,654 shares of the company's stock valued at $153,861,000 after buying an additional 227,418 shares in the last quarter. Jennison Associates LLC grew its stake in Celsius by 2.4% in the 1st quarter. Jennison Associates LLC now owns 1,298,521 shares of the company's stock valued at $46,072,000 after buying an additional 30,327 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in Celsius in the 2nd quarter valued at approximately $43,040,000. Janus Henderson Group PLC grew its stake in Celsius by 35.3% in the 1st quarter. Janus Henderson Group PLC now owns 1,058,503 shares of the company's stock valued at $37,565,000 after buying an additional 276,369 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Celsius by 1.8% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,203,942 shares of the company's stock valued at $35,251,000 after buying an additional 21,025 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

Key Headlines Impacting Celsius

Here are the key news stories impacting Celsius this week:

• Positive Sentiment: Q3 results beat expectations: Celsius reported earnings of $0.41 per share versus the $0.34 consensus and revenue of $847.23 million versus estimates of $800.63 million. Revenue rose 16.8% year over year, setting a record and providing the clearest near-term positive catalyst. Celsius Holdings Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Needham raised its target: Needham & Company lifted its price target from $35 to $40 and maintained a “Buy” rating, implying 33.2% upside from the cited $30.03 price. Needham analyst recommendations
• Positive Sentiment: Growth plans broaden: Celsius outlined a brand-led operating structure and aims for non-U.S. sales to exceed 15% of revenue within five years. These plans could create additional growth opportunities, though execution will matter. Celsius outlines international revenue goals and new structure
• Neutral Sentiment: Analyst views are mixed: While Needham raised its target, Stifel lowered its target to $36. That target remains above the cited share price, but the contrasting revisions suggest differing views on the outlook. Stifel lowers Celsius price target
• Negative Sentiment: Core-brand softness and legal overhang: Reports say Alani Nu is helping drive growth as the namesake Celsius brand slides. Separately, Celsius faces a class-action lawsuit alleging “healthwashing,” which could create reputational or legal risk; the allegations are not a court finding. Bloomberg report on Alani Nu and the Celsius brand Food Dive report on lawsuit

About Celsius

Celsius Holdings, Inc NASDAQ: CELH develops, markets and distributes functional beverages designed to support active lifestyles. Its flagship CELSIUS brand offers carbonated and non-carbonated energy drinks, including products positioned around energy, fitness and wellness. The company also markets CELSIUS Essentials, CELSIUS Vibe and powdered drink mixes, with product formulations that commonly feature ingredients such as caffeine, vitamins and other functional components.

Founded in 2004, Celsius has expanded from a niche fitness beverage business into a broader energy-drink platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.